Skip to main content

Advertisement

SpringerLink
Log in

Hormones and cytokines in childhood obesity

  • Perspective
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

Obesity is a growing worldwide health problem affecting both adults and children. Effective prevention and treatment modalities can be achieved by understanding the pathogenesis of obesity better. This review addresses some of the issues related to the hormones and cytokines taking part in the pathogenesis of obesity, energy balance and inflammation.

Design

We reviewed current literature on this broad subject especially concentrating on the functions of the hormones and cytokines taking part in the pathogenesis of the childhood obesity. Using the key words “obesity, children, hormones, cytokines” publications and cross references were evaluated from PubMed database between 1957 and 2009.

Results

In children, leptin and ghrelin are two hormones which have major influence on energy balance. Leptin is responsible from long term regulation of energy balance and ghrelin functions as an appetite stimulatory signal. In contrast to ghrelin, obestatin acts as an anorexigenic hormone by suppressing food intake. Adipokines secreted from adipose tissue are the key regulators of inflammation in obesity. Increased TNF-alpha and IL-6 levels but decreased levels of adiponectin and IL-10 are associated with increased inflammation, tissue injury and complications of obesity.

Conclusions

Development, pathogenesis and complications of childhood obesity consist of complex mechanisms including numerous cytokines and hormones. New treatment modalities depend on understanding these complex mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organisation. Childhood overweight and obesity. 2008. www.who.int/dietphysicalactivity/childhood/en/index.html. Accessed on August 15, 2010.

  2. Devi S. Progress on childhood obesity patchy in the USA. Lancet 2008; 371: 105–106.

    Article  PubMed  Google Scholar 

  3. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic syndrome in Turkish children and adolescents. Metabolism 2006; 55: 1002–1006.

    Article  CAS  PubMed  Google Scholar 

  4. Olds TS, Tomkinson GR, Ferrar KE, Maher CA. Trends in the prevalence of childhood overweight and obesity in Australia between 1985 and 2008. Int J Obes (Lond) 2009; Oct 13: [Epub ahead of print].

  5. Ji CY, Cheng TO. Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005. Int J Cardiol 2009; 132: 1–10.

    Article  PubMed  Google Scholar 

  6. Branca F, Nikogosian H, Lobstein T (eds). The Challenge of Obesity in the WHO European Region and the Strategies for Response. Copenhagen, WHO Regional Office for Europe 2007.

    Google Scholar 

  7. Greydanus DE, Bhave S. Obesity and adolescents; time for increased physical activity. Indian Pediatr 2004; 41: 545–550.

    PubMed  Google Scholar 

  8. Aziz S, Noorulain W, Zaidi UE, Hossain K, Siddiqui IA. Prevalence of overweight and obesity among children and adolescents of affluent schools in Karachi. J Pak Med Assoc 2009; 59: 35–38.

    PubMed  Google Scholar 

  9. Ziraba AK, Fotso JC, Ochako R. Overweight and obesity in urban Africa: A problem of the rich or the poor? BMC Public Health 2009; 9: 465–473.

    Article  PubMed  Google Scholar 

  10. Gregor MF, Hotamisligil GS. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 2007; 48: 1905–1914.

    Article  CAS  PubMed  Google Scholar 

  11. Trayhurn P. Adipocyte biology. Obes Rev 2007; 8: 41–44.

    Article  CAS  PubMed  Google Scholar 

  12. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–660.

    Article  CAS  PubMed  Google Scholar 

  13. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21–34.

    Article  CAS  PubMed  Google Scholar 

  14. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714–1719.

    Article  CAS  PubMed  Google Scholar 

  15. Foster CM, Barkan A, Kasa-Vubu JZ, Jaffe C. Ghrelin concentrations reflect body mass index rather than feeding status in obese girls. Pediatr Res 2007; 6: 731–733.

    Article  Google Scholar 

  16. Zou CC, Liang L, Wang CL, Fu JF, Zhao ZY. The change in ghrelin and obestatin levels in obese children after weight reduction. Acta Paediatr 2009; 98: 159–165.

    Article  CAS  PubMed  Google Scholar 

  17. Stylianou C, Galli-Tsinopoulou A, Farmakiotis D, Rousso I, Karamouzis M, Koliakos G, et al. Ghrelin and leptin levels in obese adolescents. Relationship with body fat and insulin resistance. Hormones (Athens) 2007; 6: 295–303.

    Google Scholar 

  18. Galli-Tsinopoulou A, Stylianou C, Farmakiotis D, Rousso I, Karamouzis M, Nousia-Arvanitakis S. Ghrelin serum levels during oral glucose tolerance test in prepubertal obese children with insulin resistance. J Pediatr Endocrinol Metab 2007; 20: 1085–1092.

    CAS  PubMed  Google Scholar 

  19. Maffeis C, Bonadonna C, Consolaro A, Vettor R, Banzato C, Silvagni D, et al. Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. Eur J Endocrinol 2006; 154: 61–68.

    Article  CAS  PubMed  Google Scholar 

  20. Iñiguez G, Ong K, Peña V, Avila A, Dunger D, Mericq V. F Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age. J Clin Endocrinol Metab 2002; 87: 5830–5833

    Article  PubMed  Google Scholar 

  21. Krohn K, Boczan C, Otto B, Heldwein W, Landgraf R, Bauer CP, Koletzko B. Regulation of ghrelin is related to estimated insulin sensitivity in obese children. Int J Obes (Lond) 2006; 30: 1482–1487.

    Article  CAS  Google Scholar 

  22. Bellone S, Rapa A, Vivenza D, Castellino N, Petri A, Bellone J, et al. Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest 2002; 25: 13–15.

    Google Scholar 

  23. Xiu-Min Wang, You-Jun Jiang, Li Liang, Li-Zhong Du. Changes of ghrelin following oral glucose tolerance test in obese children with insulin resistance. World J Gastroenterol 2008; 14: 1919–1924.

    Article  Google Scholar 

  24. Chao-Chun Zou, Li Liang, Zheng-Yan Zhao. Factors associated with fasting plasma ghrelin levels in children and adolescents. World J Gastroenterol 2008; 14: 790–794.

    Article  Google Scholar 

  25. Okamatsu Y, Matsuda K, Hiramoto I, Tani H, Kimura K, Yada Y, et al. Ghrelin and leptin modulate immunity and liver function in overweight children. Pediatr Int 2009; 51: 9–13.

    Article  CAS  PubMed  Google Scholar 

  26. Zhao CM, Furnes MW, Stenström B, Kulseng B, Chen D. Characterization of obestatin- and ghrelinproducing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331: 575–587.

    Article  CAS  PubMed  Google Scholar 

  27. Furnes WM, Stenstrom B, Tommeras K, Skoglund T, Dickson SL, Kulseng B, et al. Feeding behaviour in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res 2008; 40: 279–288.

    Article  CAS  PubMed  Google Scholar 

  28. Huda MS, Durham BH, Wong SP, Deepak D, Kerrigan D, McCulloch P, et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 2008; 32: 129–135.

    Article  CAS  Google Scholar 

  29. Guo ZF, Zheng X, Qin YW, Hu JQ, Chen SP, Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 2007; 92: 1875–1880.

    Article  CAS  PubMed  Google Scholar 

  30. Reinehr T, de Sousa G, Roth CL. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf) 2008; 68: 304–310.

    CAS  Google Scholar 

  31. Antunes H, Santos C, Carvalho S. Serum leptin levels in overweight children and adolescents. Br J Nutr 2008; 28: 1–5.

    Google Scholar 

  32. Holm JC, Gamborg M, Kaas-Ibsen K, Gammeltoft S, Ward L, Heitmann BL, et al. Time course and determinants of leptin decline during weight loss in obese boys and girls. Int J Pediatr Obes 2007; 2: 2–10.

    Article  PubMed  Google Scholar 

  33. Haqq AM, Farooqi IS, O’Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 2003; 88: 174–178.

    Article  CAS  PubMed  Google Scholar 

  34. Yoshinaga M, Sameshima K, Tanaka Y, Wada A, Hashiguchi J, Tahara H, et al. Adipokines and the prediction of the accumulation of cardio-vascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J 2008; 72: 1874–1878.

    Article  CAS  PubMed  Google Scholar 

  35. Zhang S, Liu X, Brickman WJ, Christoffel KK, Zimmerman D, Tsai HJ, Wang G, et al. Association of plasma leptin concentrations with adiposity measurements in rural Chinese adolescents. J Clin Endocrinol Metab 2009; 94: 3497–3504.

    Article  CAS  PubMed  Google Scholar 

  36. Kim IK, Kim J, Kang JH, Song J. Serum leptin as a predictor of fatty liver in 7-year-old Korean children. Ann Nutr Metab 2008; 53: 109–116.

    Article  CAS  PubMed  Google Scholar 

  37. Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O’Kirwan F, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004; 101: 4531–4536.

    Article  CAS  PubMed  Google Scholar 

  38. Aprath-Husmann I, Rohrig K, Gottschling-Zeller H, Skurk T, Scriba D, Birgel M, et al. Effects of leptin on the differentiation and metabolism of human adipocytes. Int J Obes Relat Metab Disord 2001; 25: 1465–1470.

    Article  CAS  PubMed  Google Scholar 

  39. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, et al. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 2003; 88: 1577–1586.

    Article  CAS  PubMed  Google Scholar 

  40. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, et al. Lowdose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579–3586.

    Article  CAS  PubMed  Google Scholar 

  41. Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V, et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 2008; 93: 3051–3057.

    Article  CAS  PubMed  Google Scholar 

  42. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527–533.

    CAS  PubMed  Google Scholar 

  43. Panagopoulou P, Galli-Tsinopoulou A, Fleva A, Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S. Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr 2008; 47: 356–362.

    Article  CAS  PubMed  Google Scholar 

  44. Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss LD, English P, et al. Adiponectin in childhood. Int J Pediatr Obes 2008; 3: 130–140.

    Article  PubMed  Google Scholar 

  45. Murphy MJ, Hosking J, Metcalf BS, Voss LD, Jeffery AN, Sattar N, et al. Distribution of adiponectin, leptin, and metabolic correlates of insulin resistance: a longitudinal study in British children; 1: Prepuberty (EarlyBird 15). Clin Chem 2008; 54: 1298–1306.

    Article  CAS  PubMed  Google Scholar 

  46. Eyzaguirre F, Mericq V. Insulin resistance markers in children. Horm Res 2009; 71: 65–74.

    Article  CAS  PubMed  Google Scholar 

  47. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439–451.

    Article  CAS  PubMed  Google Scholar 

  48. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor- BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893–2898.

    Article  CAS  PubMed  Google Scholar 

  49. Arnaiz P, Acevedo M, Barja S, Aglony M, Guzman B, Cassis B, et al. Adiponectin levels, cardiometabolic risk factors and markers of subclinical atherosclerosis in children. Int J Cardiol 2008; Sep 5: [Epub ahead of print].

  50. Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, et al. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. Eur J Clin Invest 2000; 30: 302–310.

    Article  CAS  PubMed  Google Scholar 

  51. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.

    Article  CAS  PubMed  Google Scholar 

  52. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor: A key component of the obesity-diabetes link. Diabetes 1994; 43: 1271–1278.

    Article  CAS  PubMed  Google Scholar 

  53. Greenberg, AS and McDaniel ML. Identifying the links between obesity, insulin resistance and function: Potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 2002; 32: 24–34.

    Article  CAS  PubMed  Google Scholar 

  54. Angin Y, Kuralay F, Arslan N. Evoluation of metabolic, antioxidant and oxidant systemic determinants in nonalcoholic fatty liver disease relevant to pediatric obesity. In: Sahin MF, Zefirov NS, editors, 1st Turkish-Russian Joint Meeting on Organic and Medicinal Chemistry; 2009 October 14–17; Antalya, Turkey, p. 64.

  55. Lyon CJ, Law RE, Hsueh VA. Minireview: Adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195–2200.

    Article  CAS  PubMed  Google Scholar 

  56. Gtowinska B, Urban M. Selected cytokines (Il-6, Il- 8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes. Wiad Lek 2003; 56: 109–116.

    Google Scholar 

  57. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196–4200.

    Article  CAS  PubMed  Google Scholar 

  58. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847–850.

    Article  CAS  PubMed  Google Scholar 

  59. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels, blood pressure and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: 1154–1159.

    Article  CAS  PubMed  Google Scholar 

  60. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 2001; 280: 745–751.

    Google Scholar 

  61. Yeste D, Vendrell J, Tomasini R, Broch M, Gussinyé M, Megia A, et al. Interleukin-6 in obese children and adolescents with and without glucose intolerance. Diabetes Care 2007; 30: 1892–1894.

    Article  CAS  PubMed  Google Scholar 

  62. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9: 414–417.

    Article  CAS  PubMed  Google Scholar 

  63. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–1772.

    CAS  PubMed  Google Scholar 

  64. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997; 82: 4167–4170.

    Article  CAS  PubMed  Google Scholar 

  65. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.Biochem Biophys Res Commun 2003; 301: 1045–1050.

    Article  CAS  PubMed  Google Scholar 

  66. Boden G, Shulman G I. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 2002; 32: 14–23.

    Article  CAS  PubMed  Google Scholar 

  67. Sacheck J. Pediatric obesity: an inflammatory condition? J Parenter Enteral Nutr 2008; 32: 633–637.

    Article  CAS  Google Scholar 

  68. Bhagat K, Balance P. Inflammatory cytokines impair endothelium dependent dilatation in human veins in vivo. Circulation 1997; 96: 3042–3047.

    CAS  PubMed  Google Scholar 

  69. Gunnett CA, Heistad DD, Faraci FM. Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: Role of superoxide. Diabetes 2002; 51: 1931–1937.

    Article  CAS  PubMed  Google Scholar 

  70. Esposito K, Giugliano D, Nappo F, Marfella L. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus: Campanian Postprandial Hyperglycemia Study Group. Circulation 2004; 110: 214–219.

    Article  CAS  PubMed  Google Scholar 

  71. Waters AK, Mast BT, Vella S, De La Eva R, O’Brien LM, Bailey S, et al. Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children. J Sleep Res 2007; 16: 388–395.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Gastroenterology, Metabolism and Nutrition, Dokuz Eylul University School of Medicine, Izmir, Turkey

    Nur Arslan & Baris Erdur

  2. Department of Social Pediatrics, Dokuz Eylul University School of Medicine, Izmir, Turkey

    Adem Aydin

  3. Department of Pediatric Gastroenterology, Metabolism and Nutrition, Dokuz Eylul University School of Medicine, 35340, Izmir, Turkey

    Nur Arslan

Authors
  1. Nur Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baris Erdur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adem Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nur Arslan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arslan, N., Erdur, B. & Aydin, A. Hormones and cytokines in childhood obesity. Indian Pediatr 47, 829–839 (2010). https://doi.org/10.1007/s13312-010-0142-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-010-0142-y

Key words

Search

Navigation